Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00355498 · ClinicalTrials.gov registry record
Amyloid Plaque and Tangle Imaging in Aging and Dementia
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 170
- Enrollment target
NCT00355498: Completed study, sponsored by University of California, Los Angeles.
NCT00355498 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 170 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00355498 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 170 participants
- Enrollment target
Study Summary
Amyloid senile plaques (SPs) and neurofibrillary tangles (NFTs) are neuropathological hallmarks of Alzheimer's disease (AD) that also accumulate in key brain regions in association with normal aging. This project will expand an established program in early detection and prevention of AD designed (1) to identify presymptomatic persons most likely to benefit from early intervention and (2) to provide an objective, noninvasive means to monitor therapeutic trials.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2005-09 |
| Est. Completion | 2010-05 |
What the finished NCT00355498 record still lists
NCT00355498 is an observational study that tracks outcomes without assigning an intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00355498 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00355498 about?
NCT00355498 is a clinical study titled "Amyloid Plaque and Tangle Imaging in Aging and Dementia". Amyloid senile plaques (SPs) and neurofibrillary tangles (NFTs) are neuropathological hallmarks of Alzheimer's disease (AD) that also accumulate in key brain regions in association with normal aging. This project will expand an established program in early detection and prevention of AD designed (1)...
What is the current status of trial NCT00355498?
This trial is currently completed. The enrollment target is 170 participants. The study started on 2005-09. Estimated completion is 2010-05.
Who is sponsoring clinical trial NCT00355498?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia